Improved Survival With T Cell Clonotype Stability After Anti-Ctla-4 Treatment in Cancer Patients

Science Translational Medicine - United States
doi 10.1126/scitranslmed.3008211
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Association for the Advancement of Science (AAAS)

Related search

Dose-Dependent Effect of Anti-Ctla-4 on Survival in Sepsis

Shock
Critical CareEmergency MedicineIntensive Care Medicine
2011English

Comment on ‘Efficacy and Toxicity of Treatment With the Anti-Ctla-4 Antibody Ipilimumab in Patients With Metastatic Melanoma After Prior Anti-Pd-1 Therapy’

British Journal of Cancer
Cancer ResearchOncology
2017English

Prevalence of DLL3, CTLA-4 and MSTN Expression in Patients With Small Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated With Anti-Ctla-4 Antibodies: Association With Overall Survival?

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2013English

Expression of CTLA-4 and Foxp3 in Peripheral Blood T Cells of Patients With Squamous Cell Laryngeal Carcinoma

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2013English

CTLA-4+ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate With Poor Prognosis

Cancer Research
Cancer ResearchOncology
2015English

T-Cell Landscape in a Primary Melanoma Predicts the Survival of Patients With Metastatic Disease After Their Treatment With Dendritic Cell Vaccines

Cancer Research
Cancer ResearchOncology
2016English

CTLA-4 Antibody Ipilimumab Negatively Affects CD4+ T-Cell Responses in Vitro

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2019English

Overexpression of Regulatory T Cell-Related Markers (FOXP3, CTLA-4 and GITR) by Peripheral Blood Mononuclear Cells From Patients With Breast Cancer

Asian Pacific Journal of Cancer Prevention
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy